Pune, India -- (SBWIRE) -- 05/12/2020 -- Infinium Global Research has recently published a global report on "Hypertension Drugs Market (Analysis Type - Systemic Hypertension Drugs, and Pulmonary Hypertension Drugs; Therapy Type - Calcium Channel Blockers, Diuretics, Beta Blockers Vasodilators, Angiotensin Converting Enzyme Inhibitor, Alpha Blockers, Angiotensin Receptor Blockers, and Renin Inhibitors; Distribution Channels - Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025." The global hypertension drugs market is projected to grow at a CAGR of 3.5% over the forecast period of 2019-2025.

"We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report Shall be Revised to 2020-2026. The Section on the Impact of COVID-19 on Hypertension Drugs Market is Included in the Report for Free."

For More Details Get FREE Sample Pages of this Premium Global Report@ https://www.infiniumglobalresearch.com/reports/sample-request/13287

Increasing Rates of Hypertension

The increasing rate of hypertension acts as a major driver for the growth of the hypertension drugs market. In addition, the aging population is also expected to drive the demand for hypertension drugs as they have a high risk of hypertension. Furthermore, a sedentary lifestyle and changing dietary habits have led to a significant increase in hypertension.

Increasing Research and Development

However, the high cost of hypertension drugs restraints the growth of the market. Moreover, increasing research and development is anticipated to create fruitful opportunities for the growth of the hypertension drugs market.

North America Holds the Largest Share

North America holds the largest share in the global hypertension drugs market. The U.S. is the key country that contributes to the largest revenue in the North America Hypertension Drugs market owing to the high prevalence of hypertension in the U.S. According to statistics from the American Heart Association, An estimated 103 million U.S. adults have high blood pressure.

In addition, favorable reimbursement policies contribute to the growth of the North Americahypertension drugs market. Furthermore, Asia Pacific is expected to grow at the highest CAGR over the forecast period owing to the changing lifestyle, increasing occurrence of hypertension, and rising middle-class income.

Get this Section as a Free Customization in the Report Along with 30% Discount on the Study: https://www.infiniumglobalresearch.com/reports/request-discount/13287

"We Have Decided to Extend Our Support to the Industry on Account of Corona Outbreak by Offering Flat Discount 30% on All Our Studies and Evaluation of the Market Dynamics in Hypertension Drugs Amidst COVID-19."

Hypertension Drugs Market Coverage

Chapter - 1           Preface

=> Report Description

=> Research Methods

=> Research Approaches

Chapter - 2           Executive Summary

=> Hypertension Drugs Market Highlights

=> Hypertension Drugs Market Projection

=> Hypertension Drugs Market Regional Highlights

Chapter - 3           Global Hypertension Drugs Market Overview

=> Introduction

=> Market Dynamics

=> Porter's Five Forces Analysis

=> IGR-Growth Matrix Analysis

=> Value Chain Analysis of Hypertension Drugs Market

Chapter - 4           Hypertension Drugs Market Macro Indicator Analysis

Chapter - 5           Global Hypertension Drugs Market by Analysis Type

=> Systemic Hypertension Drugs

=> Pulmonary Hypertension Drugs

Chapter - 6           Global Hypertension Drugs Market by Therapy Type

=> Calcium Channel Blockers

=> Diuretics

=> Beta Blockers Vasodilators

=> Angiotensin Converting Enzyme Inhibitor

=> Alpha Blockers

=> Angiotensin Receptor Blockers

=> Renin Inhibitors

Chapter - 7           Global Hypertension Drugs Market by Distribution Channels

=> Hospital Pharmacy

=> Retail Pharmacy

=> Online Pharmacy

Chapter - 8           Global Hypertension Drugs Market by Region 2019-2025

=> North America

=> Europe

=> Asia-Pacific

=> RoW

Chapter - 9           Company Profiles and Competitive Landscape

=> Pfizer, Inc.

=> AstraZeneca plc

=> Novartis AG

=> Daiichi Sankyo Company, Ltd.

=> United Therapeutics Corporation

=> Sanofi S.A.

=> Johnson & Johnson Services, Inc.

=> Boehringer Engelheim GmbH

=> Takeda Pharmaceutical Company

=> Bayer AG

Chapter - 10        Appendix

=> Primary Research Findings and Questionnaire

Browse Complete Report@ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-hypertension-drugs-market

About Infinium Global Research
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients.

To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations and environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.